Dow Up 0.36% Nasdaq Up 0.12%

OXiGENE, Inc. (OXGN)

-NasdaqCM
2.15 Down 0.07(3.15%) 3:59PM EDT
Prev Close:2.22
Open:2.21
Bid:2.13 x 10000
Ask:2.21 x 1000
1y Target Est:6.00
Beta:3.14
Next Earnings Date:N/A
Day's Range:2.15 - 2.22
52wk Range:1.96 - 5.40
Volume:203,905
Avg Vol (3m):404,567
Market Cap:44.52M
P/E (ttm):N/A
EPS (ttm):-3.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OXGN

Comparison

Symbol% ChgMkt Cap
OXGNDown 3.15%44.52M
AZNUp 3.08%92.44B
SNYUp 1.80%141.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):483.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops therapeutics primarily to treat cancer. The company focuses on developing vascular disrupting agents (VDAs) that disrupt abnormal blood vessels associated with solid tumor progres... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback